[1] Lee BB,Cripps RA,Fitzharris M,et al.The global map for traumatic spinal cord injury epidemiology:update 2011,global incidence rate[J].Spinal Cord,2014,52(2):110-116.
[2] Lannotti CA,Clark M,Horn KP,et al.A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI[J].Exp Neurol,2011,230(1):3-15.
[3] Crutcher KA,Gendelman HE,Kipnis J,et al.Debate:“Is Increasing Neuroinflammation Beneficial for Neural Repair?”[J].J Neuroimmune Pharmacol,2006,1(3):195-211.
[4] Luckheeram RV,Zhou R,Verma AD,et al.CD4+T cells:differentiation and functions[J].Clin Dev Immunol,2012,2012:925135.
[5] Suzuki M,Konya C,Goronzy JJ,et al.Inhibitory CD8+ T cells in autoimmune disease[J].Hum Immunol,2008,69(11):781-789.
[6] Smith TR,Kumar V.Revival of CD8+ Treg-mediated suppression[J].Trends Immunol,2008,29(7):337-342.
[7] Filaci G,Fenoglio D,Fravega M,et al.CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers[J].J Immunol,2007,179(7):4323-4334.
[8] Basso DM,Beattie MS,Bresnahan JC.A sensitive and reliable locomotor rating scale for open field testing in rats[J].J Neurotrauma,1995,12(1):1-21.
[9] Basso DM,Beattie MS,Bresnahan JC,et al.MASCIS evaluation of open field locomotor scores:effects of experience and teamwork on reliability.Multicenter Animal Spinal Cord Injury Study[J].J Neurotrauma,1996,13(7):343-359.
[10] Pardridge WM.Blood-brain barrier biology and methodology[J].J Neurovirol,1999,5(6):556-569.
[11] Thawer SG,Mawhinney L,Chadwick K,et al.Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the lys-egfp-ki mouse model[J].J Neuroimmunol,2013,261(1/2):7-20.
[12] Smoleńska Z,Pawowska J,Zdrojewski Z,et al.Increased percentage of CD8+CD28T cells correlates with clinical activity in primary Sjögren's syndrome[J].Cell Immunol,2012,278(1/2):143-151.
[13] Mikulkova Z,Praksova P,Stourac P,et al.Numerical defects in CD8+CD28T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis[J].Cell Immunol,2010,262(2):75-79.
[14] Donnelly DJ,Popovich PG.Inflammation and its role in neuroprotection,axonal regeneration and functional recovery after spinal cord injury[J].Exp Neurol, 2008, 209(2):378-388.
[15] Lee KD,Chow WN,Sato-Bigbee C,et al.FTY720 reduces inflammation and promotes functional recovery after spinal cord injury[J].J Neurotrauma,2009,26(12):2335-2344.
[16] Schwartz M.Beneficial autoimmune T cells and posttraumatic neuroprotection[J].Ann N Y Acad Sci, 2000,917:341-347.
[17] Deb C,Lafrance-Corey RG,Schmalstieg WF,et al.CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis[J].PLoS One,2010,5(8):e12478.
[18] Mueller CA,Schluesener HJ,Conrad S,et al.Spinal cord injury-induced expression of the immune-regulatory chemokine interleukin-16 caused by activated microglia/macrophages and CD8+ cells[J].J Neurosurg Spine,2006,4(3):233-240.
[19] Bieber AJ,Kerr S,Rodriguez M.Efficient central nervous system remyelination requires T cells[J].Ann Neurol,2003, 53(5):680-684.